Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Day One Biopharmaceuticals
Day One Biopharmaceuticals
Two days after showing strong pediatric cancer data, Day One taps $150M in public capital
Endpoints
Wed, 06/15/22 - 10:54 am
Day One Biopharmaceuticals
funding
tovorafenib
pediatric cancer
brain cancer
A new day for pediatric cancer patients: Day One's share price doubles on initial data for brain tumor drug
Fierce Biotech
Mon, 06/13/22 - 09:56 pm
Day One Biopharmaceuticals
tovorafenib
pediatric
pediatric cancer
brain cancer
pediatric low-grade glioma
Merck KGaA offloads clinical-phase cancer drugs to Day One
Fierce Biotech
Tue, 02/23/21 - 10:45 am
Merck KGaA
Day One Biopharmaceuticals
pimasertib
solid tumors